Coronavirus (COVID-19): Advice and guidance for our patients, plus the latest visiting restrictions
Royal Papworth Hospital NHS Foundation Trust is the UK’s leading heart and lung hospital, treating around 50,000 patients each year. The Trust is currently rated 'outstanding' by the Care Quality Commission (CQC), from an inspection carried out in 2019. It became the first hospital Trust in the country to receive the top rating of 'outstanding' in each of the five main domains that the CQC assesses.
Founded as a tuberculosis colony in 1918, Royal Papworth Hospital has established an international reputation for excellence in research and innovation. Since carrying out the UK’s first successful heart transplant in 1979, the hospital now performs more heart, heart-lung and lung transplants each year than any other UK centre.
In addition to transplantation, Royal Papworth Hospital has the UK’s largest Respiratory Support and Sleep Centre (RSSC) and is one of five UK centres providing Extra Corporeal Membrane Oxygenation (ECMO) to patients experiencing severe respiratory failure. It is also the only centre in the UK for a number of specialist services including Pulmonary Endarterectomy and Balloon Pulmonary Angioplasty (BPA).
Royal Papworth Hospital is a member of Cambridge University Health Partners (CUHP), a partnership between one of the world's leading universities and three NHS Foundation Trusts. CUHP delivers world-class excellence in healthcare, research, clinical education and improves the health of people across Cambridgeshire and the wider regions.
In 2017, the hospital was granted Royal status by Her Majesty the Queen in recognition of its commitment to excellence in cardiothoracic care.
Royal Papworth moved to a state-of-the-art building on the Cambridge Biomedical Campus in May 2019, which was officially opened by Her Majesty the Queen in July 2019.